NYSE:SQZ SQZ Biotechnologies (SQZ) Stock Price, News & Analysis → Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad) Free SQZ Stock Alerts $0.05 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.04▼$0.0552-Week Range$0.25▼$3.56Volume4 shsAverage Volume455,220 shsMarket Capitalization$1.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Get SQZ Biotechnologies alerts: Email Address Ad Chaikin AnalyticsWall Street Legend Issues New NVDA WarningLegendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.Click here for the stock details About SQZ Biotechnologies Stock (NYSE:SQZ)SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.Read More SQZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SQZ Stock News HeadlinesApril 22, 2024 | americanbankingnews.comReviewing BioAtla (NASDAQ:BCAB) and SQZ Biotechnologies (NYSE:SQZ)April 1, 2024 | bizjournals.comVC funding update: who raised money in March?April 25, 2024 | Chaikin Analytics (Ad)Wall Street Legend Issues New NVDA WarningLegendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.March 19, 2024 | finance.yahoo.comPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCDecember 28, 2023 | seekingalpha.comSQZB SQZ Biotechnologies CompanyDecember 12, 2023 | morningstar.comSQZ Biotechnologies Co Ordinary Shares SQZBNovember 8, 2023 | msn.comSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MNovember 8, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesApril 25, 2024 | Chaikin Analytics (Ad)Wall Street Legend Issues New NVDA WarningLegendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.November 4, 2023 | morningstar.comLifeline Biotechnologies Inc LLBONovember 3, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingAugust 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesAugust 3, 2023 | investing.comSqz Biotechnologies Co (SQZB)July 25, 2023 | benzinga.comSQZ Biotechnologies Provides Update on Collaboration with RocheJuly 3, 2023 | seekingalpha.comSQZ Biotechnologies to be delisted from the NYSEJuly 3, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)June 15, 2023 | finance.yahoo.comSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitMay 11, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Hold Rating on SQZ Biotechnologies (SQZ)May 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesMay 10, 2023 | finance.yahoo.comSQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue EstimatesApril 17, 2023 | finance.yahoo.comInvestors Aren't Entirely Convinced By SQZ Biotechnologies Company's (NYSE:SQZ) RevenuesMarch 29, 2023 | msn.comSQZ Biotechnologies's Return On Capital Employed InsightsMarch 24, 2023 | benzinga.comShort Volatility Alert: Sqz BiotechnologiesMarch 24, 2023 | markets.businessinsider.comBTIG Remains a Buy on SQZ Biotechnologies (SQZ)March 23, 2023 | finance.yahoo.comSQZ Biotech's Cancer Candidate Shows Response At Low Dose In HPV16+ Solid Tumor PatientMarch 22, 2023 | marketwatch.comStocks to Watch: Coinbase, Agile Therapeutics, Steelcase, SQZ BiotechnologiesMarch 22, 2023 | marketwatch.comSQZ Biotechnologies Shares Advance 44% on Continued AAC TrialSee More Headlines Receive SQZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNYSE:SQZ CUSIPN/A CIK1604477 Webwww.sqzbiotech.com Phone617-758-8672FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-79,460,000.00 Net Margins-369.96% Pretax Margin-408.99% Return on Equity-119.83% Return on Assets-59.90% Debt Debt-to-Equity RatioN/A Current Ratio3.50 Quick Ratio3.50 Sales & Book Value Annual Sales$18.16 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value$1.94 per share Price / Book0.02Miscellaneous Outstanding Shares29,491,000Free Float24,772,000Market Cap$1.37 million OptionableNot Optionable Beta2.34 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Howard Bernstein M.D. (Age 66)Ph.D., Interim CEO & Director Comp: $552.14kMr. Lawrence J. Knopf Esq. (Age 61)Gen. Counsel Comp: $512.38kDr. Marshelle Smith Warren M.D. (Age 60)Chief Medical Officer Comp: $476.27kDr. Robert S. Langer Jr. (Age 74)Ph.D., Sc.D., SCD, Co-Founder & Member of Scientific Advisory Board Mr. Richard V. Capasso CPA (Age 61)Chief Accounting Officer Mr. David First (Age 59)Chief People Officer Ipsita Roymoulik Ph.D.Sr. VP of CMC & QUALITYMore ExecutivesKey CompetitorsTC BiopharmNASDAQ:TCBPScinai ImmunotherapeuticsNASDAQ:SCNIAcorda TherapeuticsNASDAQ:ACORAcorda TherapeuticsNASDAQ:ACORQGamida CellNASDAQ:GMDAView All Competitors SQZ Stock Analysis - Frequently Asked Questions How have SQZ shares performed in 2024? SQZ Biotechnologies' stock was trading at $0.0199 at the beginning of the year. Since then, SQZ shares have increased by 133.7% and is now trading at $0.0465. View the best growth stocks for 2024 here. How were SQZ Biotechnologies' earnings last quarter? SQZ Biotechnologies (NYSE:SQZ) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($8.00) EPS for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The firm earned $4.76 million during the quarter, compared to analyst estimates of $11.64 million. SQZ Biotechnologies had a negative trailing twelve-month return on equity of 119.83% and a negative net margin of 369.96%. When did SQZ Biotechnologies' stock split? SQZ Biotechnologies shares reverse split on the morning of Friday, July 7th 2023. The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did SQZ Biotechnologies IPO? SQZ Biotechnologies (SQZ) raised $75 million in an initial public offering (IPO) on Friday, October 30th 2020. The company issued 4,400,000 shares at a price of $16.00-$18.00 per share. BofA Securities and Stifel served as the underwriters for the IPO and BTIG was co-manager. How do I buy shares of SQZ Biotechnologies? Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SQZ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWall Street Legend Issues New NVDA WarningChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
